These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 32365480)

  • 21. Gut microbiota in chronic kidney disease.
    Cigarran Guldris S; González Parra E; Cases Amenós A
    Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.
    Lau WL; Vaziri ND
    J Ren Nutr; 2017 Nov; 27(6):458-461. PubMed ID: 29056165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation and gut dysbiosis as drivers of CKD-MBD.
    Evenepoel P; Stenvinkel P; Shanahan C; Pacifici R
    Nat Rev Nephrol; 2023 Oct; 19(10):646-657. PubMed ID: 37488276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients.
    Yang CY; Tarng DC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():16-20. PubMed ID: 30298666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in chronic kidney disease.
    Yang J; Lim SY; Ko YS; Lee HY; Oh SW; Kim MG; Cho WY; Jo SK
    Nephrol Dial Transplant; 2019 Mar; 34(3):419-428. PubMed ID: 29939312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In and out of the bone: can the osteocyte escape skeletal jail and yet regulate mineralization?
    Kazama JJ; Fukagawa M
    Kidney Int; 2014 Jan; 85(1):11-2. PubMed ID: 24380901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease.
    Neven E; Bashir-Dar R; Dams G; Behets GJ; Verhulst A; Elseviers M; D'Haese PC
    J Bone Miner Res; 2015 Dec; 30(12):2313-24. PubMed ID: 26108730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of the chronic kidney disease-mineral bone disorder.
    Hruska KA; Seifert M; Sugatani T
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):303-9. PubMed ID: 26050115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gut flora modulates intestinal barrier integrity but not progression of chronic kidney disease in hyperoxaluria-related nephrocalcinosis.
    Konrad L; Andersen K; Kesper MS; Kumar SV; Mulay SR; Anders HJ
    Nephrol Dial Transplant; 2020 Jan; 35(1):86-97. PubMed ID: 31081025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urea and impairment of the Gut-Kidney axis in Chronic Kidney Disease.
    Di Iorio BR; Marzocco S; Nardone L; Sirico M; De Simone E; Di Natale G; Di Micco L
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
    Li F; Wang M; Wang J; Li R; Zhang Y
    Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revitalizing the Gut Microbiome in Chronic Kidney Disease: A Comprehensive Exploration of the Therapeutic Potential of Physical Activity.
    Vandecruys M; De Smet S; De Beir J; Renier M; Leunis S; Van Criekinge H; Glorieux G; Raes J; Vanden Wyngaert K; Nagler E; Calders P; Monbaliu D; Cornelissen V; Evenepoel P; Van Craenenbroeck AH
    Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of gut microbiota on kidney function and pathogenesis.
    Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
    Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Kidney Disease-Mineral Bone Disorder in the Elderly Peritoneal Dialysis Patient.
    Heaf JG
    Perit Dial Int; 2015 Nov; 35(6):640-4. PubMed ID: 26702005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBDs): What the Endocrinologist Needs to Know.
    Zangeneh F; Clarke BL; Hurley DL; Watts NB; Miller PD
    Endocr Pract; 2014 May; 20(5):500-16. PubMed ID: 24325991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary Fibre Intake Is Associated with Serum Levels of Uraemic Toxins in Children with Chronic Kidney Disease.
    El Amouri A; Snauwaert E; Foulon A; Vande Moortel C; Van Dyck M; Van Hoeck K; Godefroid N; Glorieux G; Van Biesen W; Vande Walle J; Raes A; Eloot S
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.
    Larivière R; Gauthier-Bastien A; Ung RV; St-Hilaire J; Mac-Way F; Richard DE; Agharazii M
    J Hypertens; 2017 Feb; 35(2):376-384. PubMed ID: 28005706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.
    Glorieux G; Gryp T; Perna A
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of Sarcopenia in Chronic Kidney Disease-The Role of Inflammation, Metabolic Dysregulation, Gut Dysbiosis, and microRNA.
    Bakinowska E; Olejnik-Wojciechowska J; Kiełbowski K; Skoryk A; Pawlik A
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.